Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 20
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
Phase III, Phase II
20050113
NCT00243685
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
Phase III, Phase II
WIRB 20060042
NCT00443196
Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
Phase II
Å6-003
NCT00083928
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
Phase II
04-247
NCT00129727
DOXIL for Consolidation Therapy in Ovarian Cancer.
Phase II
SEGO_DOXIL_CONS2005
NCT00248248
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Phase II
IP-REM-AC-02-US
NCT00326885
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase II
CINJ-3330
NCT00161187
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
Phase II
WalkerIP
NCT00582205
Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
Phase II
EC-FV-04
NCT00722592
A Study of GDC-0449 As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission
Phase II
SHH4489g
NCT00739661
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute